Trial NCT03722108

View at ClinicalTrials.gov 
Org. Study IDs: UC-0110/1807
Secondary IDs: 2018-002374-46

Last trial update was posted on 2023-10-16

MeSH Interventions

Irinotecan

MeSH Conditions

Adenocarcinoma

Other Conditions

Adenocarcinoma of the Gastroesophageal Junction Adenocarcinoma of the Stomach

Stopping Reasons

Unfavorable benefit-risk balance in the experimental arm following the IDMC for intermediate efficacy and safety analysis

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID